Work

KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia

Year: 2020

Type: article

Source: Leukemia

DOI: 10.1038/s41375-020-0978-7

Authors: Disha Malani, Bhagwan Yadav, Ashwini Kumar, Swapnil Potdar, Mika Kontro, Matti Kankainen, Komal K. Javarappa, Kimmo Porkka, Maija Wolf, Tero Aittokallio, Krister Wennerberg, Caroline A. Heckman, Astrid Murumägi, Olli Kallioniemi

Institutions: University of Helsinki, Institute for Molecular Medicine Finland, HiLIFE – Elämäntieteiden Instituutti, Helsinki University Hospital, Oslo University Hospital, University of Oslo, University of Copenhagen, Novo Nordisk Foundation, Science for Life Laboratory, Karolinska Institutet

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Pfizer, Celgene, Helsingin Yliopisto, Suomen Lääketieteen Säätiö, Stiftelsen för Strategisk Forskning, Academy of Finland, Suomen Kulttuurirahasto, Tekes, Knut och Alice Wallenbergs Stiftelse, Novo Nordisk, Sigrid Juséliuksen Säätiö, Syöpäjärjestöt, Novo Nordisk Fonden, Stiftelsen för Strategisk Forskning, Business Finland, Etelä-Karjalan Rahasto

Awards: G3589578894, G7044228676

OpenAlex ID: W3042225370

FWCI: 0.947

Cites: 15

Cited by: 9

Related to: 10